Whereas short-acting GLP1RAs suppress postprandial hyperglycemia mainly by delaying gastric emptying, long-acting GLP1RAs such as dulaglutide and liraglutide lower fasting and postprandial BS by enhancing insulin secretion and reducing glucagon secretion [14-16]. Here, INS is linked to Hyperglycemia.